# Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

> **NCT01812018** · PHASE2 · UNKNOWN · sponsor: **Peng Yuan** · enrollment: 30 (estimated)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Endostar
- **DRUG:** Gemcitabine
- **DRUG:** Docetaxel

## Key facts

- **NCT ID:** NCT01812018
- **Lead sponsor:** Peng Yuan
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2015-04
- **Final completion:** 2015-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01812018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01812018, "Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01812018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*